Tagged: verseon

March 18, 2019 @ 2:24 pm By JD Alois  |  

Verseon (AIM: VERS), a California based clinical stage pharma company, is issuing preferred shares. The company is using its own blockchain based subsidiary BlockRules to sell the securities in a security token offering (STO) that seeks to be “one of the first global offerings backed… Read More

January 22, 2019 @ 9:51 am By JD Alois  |  

Verseon (AIM: VSN), a company that provides a “computer-driven approach to drug discovery” says it is trying to change the capital markets landscape by bringing regulatory certainty to the blockchain with the goal of connecting a global investor community with innovative companies in biotech and more. Last… Read More